Press Release: Savara : Savara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business Update
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the
Read full article »
Savara is a Texas-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of respiratory diseases.
Read more